LPL Financial’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Buy
864,630
+406,571
+89% +$2.78M ﹤0.01% 2388
2025
Q4
$907K Sell
458,059
-161,231
-26% -$365K ﹤0.01% 4171
2025
Q3
$1.52M Buy
619,290
+312,787
+102% +$806K ﹤0.01% 3582
2025
Q2
$809K Buy
306,503
+111,357
+57% +$299K ﹤0.01% 3941
2025
Q1
$587K Sell
195,146
-62,303
-24% -$189K ﹤0.01% 4022
2024
Q4
$659K Buy
257,449
+103,495
+67% +$431K ﹤0.01% 3849
2024
Q3
$573K Buy
153,954
+33,552
+28% +$155K ﹤0.01% 3880
2024
Q2
$761K Buy
120,402
+59,727
+98% +$394K ﹤0.01% 3502
2024
Q1
$326K Buy
60,675
+18,002
+42% +$81.5K ﹤0.01% 4135
2023
Q4
$214K Buy
42,673
+29,756
+230% +$93.4K ﹤0.01% 4345
2023
Q3
$21.8K Buy
+12,917
New +$25.9K ﹤0.01% 4600
2021
Q2
Sell
-64,205
Closed -$1.52M 4261
2021
Q1
$1.52M Buy
+64,205
New +$1.66M ﹤0.01% 2043

Other funds holding IBRX